American Association for the Advancement of Science, Science Signaling, 643(13), 2020
DOI: 10.1126/scisignal.aay3258
Full text: Unavailable
A platform for comparing trans-omics datasets between IBD mouse models and human patients reveals therapeutically relevant targets.